Marex Group (MRX) CEO sells 37,142 shares, retains 2,803,960
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Marex Group Ltd Chief Executive Officer Ian T. Lowitt reported open-market sales of 37,142 ordinary shares on July 13, 2026, at prices ranging from $63.66 to $66.09, under a pre-arranged Rule 10b5-1 plan. After these transactions he directly holds 2,803,960 ordinary shares, including 194,411 underlying deferred bonus plan awards.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 37,142 shares ($2,391,703)
Net Sell
3 txns
Insider
Lowitt Ian T
Role
Chief Executive Officer
Sold
37,142 shs ($2.39M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 27,398 | $64.1857 | $1.76M |
| Sale | Ordinary Shares | 8,957 | $64.9017 | $581K |
| Sale | Ordinary Shares | 787 | $65.8433 | $52K |
Holdings After Transaction:
Ordinary Shares — 2,803,960 shares (Direct)
Footnotes (1)
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $63.66 to $64.6533, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.66 to $65.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.66 to $66.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Key Figures
Shares sold: 37,142 shares
Lowest sale price: $63.66 per share
Highest sale price: $66.09 per share
+3 more
6 metrics
Shares sold
37,142 shares
Total ordinary shares sold in open-market transactions on July 13, 2026
Lowest sale price
$63.66 per share
Lower end of price range for the July 13, 2026 sales
Highest sale price
$66.09 per share
Upper end of price range for the July 13, 2026 sales
Shares owned after transactions
2,803,960 shares
Directly held Marex Group ordinary shares reported after July 13, 2026 sales
Deferred bonus plan awards
194,411 shares
Ordinary shares underlying deferred bonus plan awards included within reported holdings
Rule 10b5-1 plan date
March 12, 2026
Date Ian T. Lowitt entered the Rule 10b5-1 trading plan governing these sales
Key Terms
Rule 10b5-1 plan, weighted average price, deferred bonus plan awards, contingent right
4 terms
Rule 10b5-1 plan financial
"The sale reported ... was effected pursuant to a Rule 10b5-1 plan entered..."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
deferred bonus plan awards financial
"includes 194,411 shares underlying deferred bonus plan awards previously granted"
Deferred bonus plan awards are payments promised to employees or executives that are earned now but paid out later, often only if certain performance goals are met or the employee remains with the company. For investors, they matter because they influence management’s incentives and company expenses over time—like a delayed paycheck that encourages someone to stay and meet targets—and can affect future cash needs, reported compensation costs, and potential share dilution.
contingent right financial
"Each award represents a contingent right to receive one (1) ordinary share"
FAQ
What are the deferred bonus plan awards mentioned for Marex Group (MRX) CEO Ian T. Lowitt?
His reported holdings include 194,411 shares underlying deferred bonus plan awards. Each award represents a contingent right to receive one ordinary share of Marex Group upon vesting and settlement, meaning part of his position is tied to future compensation vesting.